Latest News about Jazz
Recent news which mentions Jazz
2 Top Biotech Stocks to Buy in April
April 04, 2023
From Motley Fool
The 3 Best Growth Stocks to Buy in the Biotech Sector
March 29, 2023
Tags
NASDAQ:AXSM,NASDAQ:RETA,NASDAQ:CRSP,NASDAQ:JAGLX,NYSEARCA:XBI,NASDAQ:JAZZ,NASDAQ:VRTX
JAZZ
Stocks to Buy
From InvestorPlace
Is Big Pharma Coming For Your Cannabis Business?
March 27, 2023
From Benzinga
My Top Cannabis Stock to Buy in 2023 and Hold For 10 Years
March 21, 2023
Tickers
JAZZ
From Motley Fool
Medical Marijuana Milestone In The UK: Celadon Pharmaceuticals Becomes First Company With License To Sell In Britain
March 14, 2023
From Benzinga
Silicon Valley Bank Failure Is Just The Tip Of Financial Iceberg, Could Affect Unexpected Industries
March 14, 2023
From Benzinga
With Access To $20 Million In Financing, 1606 Corp Is Eyeing CBD Business Acquisitions As It Embarks On An Aggressive Growth Path
March 08, 2023
From Benzinga
From Benzinga
Why Cannabis Is Recession-Resistant & Turning Challenges Into Opportunities, Industry Expert Explains
March 02, 2023
From Benzinga
Earnings Scheduled For March 1, 2023
March 01, 2023
From Benzinga
Cannabis-Based Medicine As A Potential Treatment For Psychosis, An Oxford University Study Says
February 17, 2023
Tickers
JAZZ
From Benzinga
2 Cannabis Stocks That Could Make You Richer
February 09, 2023
From Motley Fool
CBD-Based Life-Changing Drug For Tuberous Sclerosis Patients, Epidiolex, Now Available Via England's NHS
February 02, 2023
Tickers
JAZZ
From Benzinga
Bob Holz New Video with Darryl Jones of the Rolling Stones, Concert, Album and Endorsement
January 31, 2023
Tickers
JAZZ
From PRLog
3 Cannabis Stocks With Double-Digit Percentage Revenue Growth
January 30, 2023
From Motley Fool
The Ultimate Growth Stocks to Buy With $300 Right Now
January 29, 2023
From Motley Fool
FDA says it will not regulate CBD and calls on Congress to act
January 26, 2023
Tickers
JAZZ
Tags
JAZZ
From MarketWatch
2 Promising New Growth Stocks to Watch in 2023
January 23, 2023
From Motley Fool
Jazz Pharma, Zymeworks Highlight 84% Overall Survival At 18 Months From Zanidatamab In Esophageal Cancer
January 19, 2023
From Benzinga
From Motley Fool
From Motley Fool
Will Investors Notice Exciting Sign On Jazz Pharmaceuticals's Chart?
January 06, 2023
Tickers
JAZZ
From Benzinga
Jazz Pharmaceuticals Files Patent Infringement Against Generic Drugmakers In New Jersey's District Court
January 05, 2023
From Benzinga
2 Cannabis Stocks to Buy for the Long Haul
December 31, 2022
From Motley Fool
2 Growth Stocks to Buy Heading Into 2023
December 30, 2022
From Motley Fool
2 Top Biotech Stocks to Buy for the Long Haul
December 25, 2022
From Motley Fool
Better Buy: Moderna vs Axsome
December 22, 2022
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.